Toronto Dominion Bank’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-21
Closed 1696
2023
Q1
$0 Buy
+21
New +$193 ﹤0.01% 1632
2022
Q3
Sell
-19
Closed -$1K 1666
2022
Q2
$1K Sell
19
-15,361
-100% -$796K ﹤0.01% 1255
2022
Q1
$1.13M Buy
15,380
+1,426
+10% +$127K ﹤0.01% 896
2021
Q4
$2M Buy
13,954
+4,012
+40% +$689K ﹤0.01% 837
2021
Q3
$2.06M Sell
9,942
-95
-0.9% -$20.9K ﹤0.01% 748
2021
Q2
$2.13M Buy
+10,037
New +$1.84M ﹤0.01% 735

Other funds holding NVAX

Toronto Dominion Bank's NVAX Position: Q2 2023 in Review

Toronto Dominion Bank sold out of Novavax (NVAX) in Q2 2023, closing a stake of 21 shares.

Toronto Dominion Bank first reported a position in NVAX in Q2 2021 and held it in 6 quarters. The position peaked at $2.13M in Q2 2021. 215 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.

  • Toronto Dominion Bank reported no remaining Novavax position as of Q2 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 21 Novavax shares in Q2 2023.
  • Toronto Dominion Bank first reported a position in Novavax in Q2 2021 and held it in 6 quarters.
  • Toronto Dominion Bank's Novavax position peaked at $2.13M in Q2 2021.
  • 215 funds tracked by Wall St. Rank held Novavax as of Q2 2023.

Based on Toronto Dominion Bank's 13F filing for Q2 2023, filed 10 Aug 2023.